Alzamend Neuro, Inc. (ALZN)
1.02
-0.04
(-3.77%)
USD |
NASDAQ |
Apr 01, 16:00
0.9833
-0.04
(-3.60%)
After-Hours: 20:00
Alzamend Neuro Market Cap : 3.695M for April 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Allogene Therapeutics, Inc. | 654.76M |
| ACADIA Pharmaceuticals, Inc. | 3.818B |
| Agenus, Inc. | 133.29M |
| Alnylam Pharmaceuticals, Inc. | 43.34B |
| Savara, Inc. | 1.166B |
Market Cap Related Metrics
| Price to Book Value | 1.691 |
| Price | 1.02 |
| Earnings Yield | -450.5% |